| 17.05.2022 07:00 | ETX | Notice of AGM and Posting of Annual Report | RNS |
| 04.05.2022 14:11 | ETX | IN BRIEF: e-Therapeutics doubles annual loss as research costs surge | Alliance |
| 04.05.2022 07:00 | ETX | Final results for the year ended 31 January 2022 | RNS |
| 27.04.2022 16:08 | WAND, TRB, SNWS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 27.04.2022 07:00 | ETX | Notification of Full Year Results Date | RNS |
| 12.04.2022 21:28 | AMTE, FDBK, ETX | TRADING UPDATES: Hornby sales rise; Victoria weathers inflation | Alliance |
| 12.04.2022 07:00 | ETX | Key Milestone Achieved on Galapagos Collaboration | RNS |
| 05.04.2022 21:39 | ATYM, AFX, GLAN | TRADING UPDATES: Alpha FX restarts relationship; Atalaya resources up | Alliance |
| 05.04.2022 07:00 | ETX | Immuno-Oncology Research Collaboration with iTeos | RNS |
| 16.02.2022 16:41 | ETX | Holding(s) in Company | RNS |
| 16.02.2022 11:47 | ETX | Holding(s) in Company | RNS |
| 15.02.2022 15:27 | ETX | Holding(s) in Company | RNS |
| 31.01.2022 07:00 | ETX | Total Voting Rights | RNS |
| 20.01.2022 10:58 | ETX | New Corporate Website | Reach |
| 18.01.2022 16:41 | ETX | Holding(s) in Company | RNS |
| 07.01.2022 07:00 | ETX | Director Dealing and Issue of Equity | RNS |
| 22.11.2021 07:00 | ETX | Senior Management Update | RNS |
| 26.10.2021 13:55 | ETX | Director Dealing | RNS |
| 26.10.2021 07:01 | ETX | Interim results for six months ended 31 July 2021 | RNS |
| 26.10.2021 07:00 | ETX | RNAi Platform Characterisation Results | RNS |
| 20.10.2021 07:00 | ETX | Investor Presentation | Reach |
| 11.10.2021 07:05 | ETX | Patent Filing Applications | RNS |
| 11.10.2021 07:00 | ETX | Notice of Interim Results | RNS |
| 24.09.2021 07:00 | ETX | Commencement of trading on the OTCQX Best Market | RNS |
| 02.09.2021 16:41 | ETX | Second Price Monitoring Extn | RNS |
| 02.09.2021 16:35 | ETX | Price Monitoring Extension | RNS |
| 30.07.2021 07:00 | ETX | Total Voting Rights | RNS |
| 06.07.2021 07:00 | ETX | Director Dealing and Issue of Equity | RNS |
| 02.07.2021 07:00 | ETX | Further milestone in Galapagos collaboration | RNS |
| 30.06.2021 07:00 | ETX | Total Voting Rights | RNS |
| 21.06.2021 15:13 | ETX | Holding(s) in Company | RNS |
| 21.06.2021 07:00 | MNG, ETX | Holding(s) in Company | RNS |
| 18.06.2021 12:52 | ETX | Holding(s) in Company | RNS |
| 17.06.2021 15:44 | ETX | Holding(s) in Company | RNS |
| 16.06.2021 13:27 | ETX | Result of AGM | RNS |
| 02.06.2021 07:00 | ETX | Senior Management Appointment and Options Grant | RNS |
| 21.05.2021 07:00 | ETX | Notice of AGM and Posting of Annual Report | RNS |
| 14.05.2021 07:00 | ETX | Results of conditional Fundraise to raise £22.5m | RNS |
| 13.05.2021 16:50 | ETX | Retail Offer | RNS |
| 13.05.2021 16:45 | ETX | Proposed Fundraise in excess of £20 million | RNS |
| 13.05.2021 07:00 | ETX | Final Results for the Year Ended 31 January 2021 | RNS |
| 06.05.2021 07:00 | ETX | Notification of Full Year Results Date | RNS |
| 23.04.2021 07:00 | ETX | ETX to receive two payments from Galapagos | RNS |
| 29.03.2021 07:00 | ETX | Appointment of Chief Financial Officer | RNS |
| 01.03.2021 07:00 | ETX | Change of Adviser | RNS |
| 01.03.2021 07:00 | ETX | Board Changes | RNS |
| 25.02.2021 15:29 | ETX | Holding(s) in Company | RNS |
| 16.02.2021 07:00 | ETX | e-therapeutics to present at Shares Evening | Reach |
| 10.02.2021 16:35 | ETX | Holding(s) in Company | RNS |
| 01.02.2021 07:00 | ETX | RNA Therapeutics Platform | RNS |
| 28.01.2021 16:40 | ETX | Second Price Monitoring Extn | RNS |
| 28.01.2021 16:35 | ETX | Price Monitoring Extension | RNS |
| 14.01.2021 16:41 | ETX | Second Price Monitoring Extn | RNS |
| 14.01.2021 16:36 | ETX | Price Monitoring Extension | RNS |
| 12.01.2021 11:24 | ETX | Holding(s) in Company | RNS |
| 04.01.2021 16:31 | ETX | Director/PDMR Shareholding | RNS |
